Rocco D. Gogliotti

1.5k total citations
31 papers, 1.1k citations indexed

About

Rocco D. Gogliotti is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases. According to data from OpenAlex, Rocco D. Gogliotti has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Infectious Diseases. Recurrent topics in Rocco D. Gogliotti's work include Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (7 papers) and HIV/AIDS drug development and treatment (7 papers). Rocco D. Gogliotti is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (7 papers) and HIV/AIDS drug development and treatment (7 papers). Rocco D. Gogliotti collaborates with scholars based in United States, Australia and Ukraine. Rocco D. Gogliotti's co-authors include Joseph P. Sanchez, John M. Domagala, Craig W. Lindsley, Tod P. Holler, Shaun R. Stauffer, Patricia J. Harvey, Joseph A. Loo, J. M. DOMAGALA, Peter J. Tummino and Donald Hupe and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Rocco D. Gogliotti

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rocco D. Gogliotti United States	19	669	277	251	229	181	31	1.1k
Andrew F. Wilderspin United Kingdom	17	803 1.2×	319 1.2×	262 1.0×	86 0.4×	154 0.9×	26	1.2k
John O. Hui United States	19	602 0.9×	500 1.8×	483 1.9×	60 0.3×	123 0.7×	42	1.3k
Susan M. Keenan United States	19	426 0.6×	144 0.5×	72 0.3×	61 0.3×	243 1.3×	36	962
Luke A. Adams Australia	20	509 0.8×	96 0.3×	50 0.2×	122 0.5×	284 1.6×	31	1.1k
Yasien Sayed South Africa	21	589 0.9×	407 1.5×	316 1.3×	33 0.1×	235 1.3×	78	1.1k
Beatrice Macchi Italy	26	551 0.8×	262 0.9×	226 0.9×	38 0.2×	354 2.0×	101	1.7k
Yeon Gyu Yu South Korea	20	790 1.2×	88 0.3×	61 0.2×	80 0.3×	81 0.4×	73	1.2k
Walter C. Herlihy United States	16	937 1.4×	179 0.6×	268 1.1×	390 1.7×	136 0.8×	19	1.6k
J. Krucinski United States	6	1.1k 1.7×	299 1.1×	284 1.1×	55 0.2×	93 0.5×	6	1.4k
Xavier Hanoulle France	23	929 1.4×	194 0.7×	111 0.4×	56 0.2×	119 0.7×	59	1.5k

Countries citing papers authored by Rocco D. Gogliotti

Since Specialization

Citations

This map shows the geographic impact of Rocco D. Gogliotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocco D. Gogliotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocco D. Gogliotti more than expected).

Fields of papers citing papers by Rocco D. Gogliotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocco D. Gogliotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocco D. Gogliotti. The network helps show where Rocco D. Gogliotti may publish in the future.

Co-authorship network of co-authors of Rocco D. Gogliotti

This figure shows the co-authorship network connecting the top 25 collaborators of Rocco D. Gogliotti. A scholar is included among the top collaborators of Rocco D. Gogliotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocco D. Gogliotti. Rocco D. Gogliotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilston, Benjamin A., Rocco D. Gogliotti, Plamen P. Christov, et al.. (2021). A fragment‐based approach to discovery of Receptor for Advanced Glycation End products inhibitors. Proteins Structure Function and Bioinformatics. 89(11). 1399–1412. 10 indexed citations

Wang, Feng, Kyu Ok Jeon, James M. Salovich, et al.. (2018). Discovery of Potent 2-Aryl-6,7-dihydro-5 H -pyrrolo[1,2- a ]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design. Journal of Medicinal Chemistry. 61(13). 5623–5642. 50 indexed citations

Engers, Darren W., Anna L. Blobaum, Rocco D. Gogliotti, et al.. (2016). Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu₄). ACS Chemical Neuroscience. 7(9). 1192–1200. 39 indexed citations

Gogliotti, Rocco D., Anna L. Blobaum, J. Scott Daniels, et al.. (2016). Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4). Bioorganic & Medicinal Chemistry Letters. 26(13). 2984–2987. 5 indexed citations

Gogliotti, Rocco D., Darren W. Engers, Pedro M. García-Barrantes, et al.. (2016). Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy. Bioorganic & Medicinal Chemistry Letters. 26(12). 2915–2919. 3 indexed citations

Gogliotti, Rocco D., Changho Han, Charles W. Locuson, et al.. (2015). Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utility. Bioorganic & Medicinal Chemistry Letters. 25(13). 2720–2725. 11 indexed citations

Bridges, Thomas M., Jerri M. Rook, Meredith J. Noetzel, et al.. (2013). Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism. Drug Metabolism and Disposition. 41(9). 1703–1714. 36 indexed citations

Raphemot, Rene, Matthew F. Rouhier, Corey R. Hopkins, et al.. (2013). Eliciting Renal Failure in Mosquitoes with a Small-Molecule Inhibitor of Inward-Rectifying Potassium Channels. PLoS ONE. 8(5). e64905–e64905. 56 indexed citations

Rook, Jerri M., Meredith J. Noetzel, Wendy A. Pouliot, et al.. (2012). Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity. Biological Psychiatry. 73(6). 501–509. 73 indexed citations

10.

Melancon, Bruce J., Rocco D. Gogliotti, James C. Tarr, et al.. (2012). Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor. Bioorganic & Medicinal Chemistry Letters. 22(10). 3467–3472. 14 indexed citations

11.

Raphemot, Rene, Thuy Thi Thanh Nguyen, Thomas J. Utley, et al.. (2011). Discovery, Characterization, and Structure?Activity Relationships of an Inhibitor of Inward Rectifier Potassium (Kir) Channels with Preference for Kir2.3, Kir3.X, and Kir7.1. Frontiers in Pharmacology. 2. 75–75. 38 indexed citations

12.

Jones, Carrie K., Darren W. Engers, Analisa D. Thompson, et al.. (2011). Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu₄) with Oral Efficacy in an Antiparkinsonian Animal Model. Journal of Medicinal Chemistry. 54(21). 7639–7647. 50 indexed citations

13.

Protasevich, Irina I., Christie G. Brouillette, Mark E. Snow, et al.. (2004). Role of Inhibitor Aliphatic Chain in the Thermodynamics of Inhibitor Binding to Escherichia coli Enoyl-ACP Reductase and the Phe203Leu Mutant: A Proposed Mechanism for Drug Resistance. Biochemistry. 43(42). 13380–13389. 10 indexed citations

14.

Sharmeen, L, Thomas J. McQuade, Andrea Heldsinger, et al.. (2001). Inhibition of the early phase of HIV replication by an isothiazolone, PD 161374. Antiviral Research. 49(2). 101–114. 23 indexed citations

15.

Prasad, J. V. N. Vara, Joseph A. Loo, F Boyer, et al.. (1998). 2,2′-dithiobisbenzamides derived from α-, β- and γ-amino acids possessing anti-HIV activities: synthesis and structure–activity relationship. Bioorganic & Medicinal Chemistry. 6(10). 1707–1730. 21 indexed citations

16.

Domagala, John M., John P. Bader, Rocco D. Gogliotti, et al.. (1997). A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: The 2,2′-dithiobisbenzamides. Bioorganic & Medicinal Chemistry. 5(3). 569–579. 33 indexed citations

17.

Sanchez, Joseph P., Rocco D. Gogliotti, John M. Domagala, et al.. (1995). The Synthesis, Structure-Activity, and Structure-Side Effect Relationships of a Series of 8-Alkoxy- and 5-Amino-8-alkoxyquinolone Antibacterial Agents. Journal of Medicinal Chemistry. 38(22). 4478–4487. 55 indexed citations

18.

Rice, William G., Jeffrey G. Supko, Louis Malspeis, et al.. (1995). Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS. Science. 270(5239). 1194–1197. 195 indexed citations

19.

Sanchez, Joseph P., Alexander J. Bridges, J. M. DOMAGALA, et al.. (1992). New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk. Journal of Medicinal Chemistry. 35(2). 361–367. 20 indexed citations

20.

Kiely, John S., Marland P. Hutt, Townley P. Culbertson, et al.. (1991). Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine. Journal of Medicinal Chemistry. 34(2). 656–663. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact